此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Virtual Reality on Pain, Anxiety and Vital Signs During Diabetic Foot Care

2026年5月7日 更新者:Yasemin Özkul、Malatya Turgut Ozal University

The Effect of Virtual Reality Intervention on Pain Level, State Anxiety, and Vital Signs During Foot Care in Individuals With Diabetic Foot Ulcers

This study aims to determine the effects of a virtual reality (VR) intervention on pain level, state anxiety, and vital signs during foot care in individuals with diabetic foot ulcers. The study was designed as a randomized controlled trial and includes 64 individuals with diabetes (intervention=32, control=32). The intervention group will receive VR during diabetic foot care, while the control group will receive standard care. Data will be collected at pre-test and post-test using the Demographic Information Form, Vital Signs Form, State-Trait Anxiety Inventory (STAI), and Visual Analog Scale (VAS) for pain. Data analysis will be performed using SPSS 22.0.

研究概览

研究类型

介入性

注册 (实际的)

64

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Malatya
      • Malatya、Malatya、土耳其(türkiye)、4400
        • Malatya Turgut Özal University Training and Research Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Age 18 years and older Diagnosis of Type 2 Diabetes Mellitus Diabetic foot ulcer classified as Wagner stage 3 or 4 No mental or physical condition that would interfere with communication or participation No visual or hearing impairment Ability to understand and speak Turkish Willingness to participate in the study

Exclusion Criteria:

  • Presence of chronic wounds other than diabetic foot ulcer (e.g., arterial or venous ulcers) Age under 18 years

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Intervention Group (VR Group)
Participants received virtual reality (VR) intervention during diabetic foot care procedures in addition to standard care. VR was used as a non-pharmacological distraction method during the procedure.
Participants in the intervention group received virtual reality (VR) exposure during diabetic foot care procedures. A virtual reality headset was used as a non-pharmacological distraction method to reduce pain and anxiety. The VR intervention was applied during the procedure in addition to standard diabetic foot care. Vital signs such as blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure to evaluate physiological responses.
其他名称:
  • VR GLASSES
  • Standard Diabetic Foot Care
Participants in the control group received standard diabetic foot care according to institutional protocols, without any virtual reality intervention. Vital signs including blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure.
有源比较器:Control Group
Participants received standard diabetic foot care without virtual reality intervention.
Participants in the control group received standard diabetic foot care according to institutional protocols, without any virtual reality intervention. Vital signs including blood pressure, pulse rate, respiratory rate, oxygen saturation, and body temperature were monitored before and after the procedure.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Pain Level
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Pain intensity measured using the Visual Analog Scale (VAS), a 10 cm horizontal line anchored at 0 (no pain) and 10 (worst imaginable pain). Higher scores indicate greater pain. Change is calculated as post-test score minus pre-test score.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care

次要结果测量

结果测量
措施说明
大体时间
Change in State Anxiety
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
State anxiety measured using the State subscale of the State-Trait Anxiety Inventory (STAI-I), a validated 20-item self-report scale scored 20-80. Higher scores indicate greater anxiety. Change is calculated as post-test score minus pre-test score.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care

其他结果措施

结果测量
措施说明
大体时间
Change in Body Temperature
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Body temperature (°C) measured using a non-contact infrared thermometer (Life Net Medical JA-11C). Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Change in Oxygen Saturation (SpO₂)
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Peripheral oxygen saturation (SpO₂, %) measured using a fingertip pulse oximeter (Life Net Medical PFX033). Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Change in Pulse Rate
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Pulse rate (beats per minute) measured using a fingertip pulse oximeter (Life Net Medical PFX033). Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Change in Respiratory Rate
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Respiratory rate (breaths per minute) assessed by direct observation and counting by the researcher. Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Change in Systolic Blood Pressure
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Systolic blood pressure (mmHg) measured using an upper-arm automated sphygmomanometer (Omron M3 Comfort HEM-7155-E) after the participant had been seated and resting for at least 5 minutes. Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Change in Diastolic Blood Pressure
大体时间:Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care
Diastolic blood pressure (mmHg) measured using an upper-arm automated sphygmomanometer (Omron M3 Comfort HEM-7155-E) after the participant had been seated and resting for at least 5 minutes. Change is calculated as post-test value minus pre-test value.
Pre-test: approximately 5 minutes before foot care; Post-test: within 0-2 minutes after completion of foot care

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年12月9日

初级完成 (实际的)

2025年6月15日

研究完成 (实际的)

2025年6月15日

研究注册日期

首次提交

2026年4月30日

首先提交符合 QC 标准的

2026年5月7日

首次发布 (实际的)

2026年5月14日

研究记录更新

最后更新发布 (实际的)

2026年5月14日

上次提交的符合 QC 标准的更新

2026年5月7日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data (IPD) will not be shared due to patient privacy and confidentiality concerns. The data are collected within a single institutional clinical study for academic thesis purposes and are not planned for public data sharing.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅